Marzieh Dehghan Shasaltaneh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marzieh Dehghan Shasaltaneh has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Bita Soltanian
Islamic Azad Univ, Coll Sci, Dept Biol, Damghan Branch, Damghan, Iran
3 shared publicationsGholam Hossein Riazi
Laboratory of Neuro-organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran
3 shared publicationsNahid Masoudian
Islamic Azad Univ, Coll Sci, Dept Biol, Damghan Branch, Damghan, Iran
3 shared publications- Gholam Hossein Riazi
Department of Biochemistry, Institute of Biochemistry and Biophysics, University of Tehran (IBB), Tehran, Iran
2 shared publications Leila Alizadeh
Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran
2 shared publicationsNasser Naghdi
Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran
2 shared publications
Latest Publications
- 30 March 2026
- Published by Maad Rayan Publishing Company in International Journal of Basic Science in Medicine
- Vol. 11 (1) , 9-17
Computational Prediction and Evaluation of Epitope-Based Peptides Derived from FZD7 and HNF4A as Risk Factors for Gastric Cancer Towards Vaccine Design
Introduction: Gastric cancer (GC) is a multifactorial disease influenced by both environmental and genetic factors. This study aims to identify potential vaccine candidates targeting two proteins—Frizzled Homolog 7 (FZD7) and Hepatocyte Nuclear Factor 4 Alpha (HNF4A) as risk factors in the onset and progression of GC, using a computational approach. Methods: Both proteins were subjected to epitope prediction based on consensus antigenicity scores and various physicochemical parameters. B-cell and T-cell epitopes were analyzed using the IEDB platform. Results: The FZD7 protein exhibits multiple potential CD4+ and CD8+ T-cell epitopes, along with a higher probability of B-cell epitope regions compared to the well-characterized antigen HNF4A. Among the identified epitopes, RQLKVPPYL from FZD7 demonstrated high population coverage. In contrast, the HNF4A-derived epitope EWAKYIPAF showed over 69% coverage in the Japanese population. The FZD7 epitope FMIKYLMTM exhibited a strong interaction in the TCR–pMHC complex. Promising MHC class II-binding peptides were also identified, including QSWRRFYHRLSHSSK from FZD7 and IKRLRSQVQVSLEDY from HNF4A. Conclusion: Comprehensive analysis revealed that FZD7 exhibits greater potential for experimental immunogenicity assessment compared to HNF4A; however, both proteins were selected for epitope prediction and further evaluation.
- 30 March 2026
- Published by Maad Rayan Publishing Company in International Journal of Basic Science in Medicine
- Vol. 11 (1) , 9-17
Computational Prediction and Evaluation of Epitope-Based Peptides Derived from FZD7 and HNF4A as Risk Factors for Gastric Cancer Towards Vaccine Design
Introduction: Gastric cancer (GC) is a multifactorial disease influenced by both environmental and genetic factors. This study aims to identify potential vaccine candidates targeting two proteins—Frizzled Homolog 7 (FZD7) and Hepatocyte Nuclear Factor 4 Alpha (HNF4A) as risk factors in the onset and progression of GC, using a computational approach. Methods: Both proteins were subjected to epitope prediction based on consensus antigenicity scores and various physicochemical parameters. B-cell and T-cell epitopes were analyzed using the IEDB platform. Results: The FZD7 protein exhibits multiple potential CD4+ and CD8+ T-cell epitopes, along with a higher probability of B-cell epitope regions compared to the well-characterized antigen HNF4A. Among the identified epitopes, RQLKVPPYL from FZD7 demonstrated high population coverage. In contrast, the HNF4A-derived epitope EWAKYIPAF showed over 69% coverage in the Japanese population. The FZD7 epitope FMIKYLMTM exhibited a strong interaction in the TCR–pMHC complex. Promising MHC class II-binding peptides were also identified, including QSWRRFYHRLSHSSK from FZD7 and IKRLRSQVQVSLEDY from HNF4A. Conclusion: Comprehensive analysis revealed that FZD7 exhibits greater potential for experimental immunogenicity assessment compared to HNF4A; however, both proteins were selected for epitope prediction and further evaluation.
- 4 August 2023
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 42 (13) , 1-17
Mechanistic studies on substrate inhibition and substrate activation of ribonuclease A: experimental and in silico investigation
Ribonuclease A (RNase A) is an endonuclease that plays a significant role in antimicrobial activity by the cleavage and hydrolysis of ssRNA. In this study, the interactions between RNase A and cCMP have been investigated, through molecular docking and a 200 ns molecular dynamics simulation. The enzyme kinetic properties were analyzed using saturation curve, Eadie-Hofstee, and Hill plots. The docking results indicate that the cCMP-RNase A complexes are stabilized through hydrophobic interaction, hydrogen bonding, and & pi;-& pi; stacking interaction. The most binding site is observed in the catalytic cleft, especially at residue His12 and His119. Enzyme-ligand docking study indicates that cCMP binds to residues located in the internal cavity of the catalytic site and shows three phases of binding modes. The analysis of MD simulations shows that RMSD, Rg, and RMSF reach equilibrium. The & UDelta;G(binding) of the cCMP-RNase A was negative (-619.673 kJ/mol), The comparison between the results pre and post MD simulation showed that & UDelta;G(binding) after MD simulation causes to more stable the structure than before simulation. Experimental methods such as saturation, Eadie-Hofstee, and Hill plots confirm theoretical data and show three phases of binding modes as well. Two significant events are demonstrated in the interaction between RNase A and cCMP: substrate activation and substrate inhibition are observed in concentrations below and above 0.8 mM, respectively, for cCMP. Choosing the appropriate concentration of cCMP is very important in investigation of ribonuclease A's catalytic behavour, especially for exploration of the effects of some drugs on biological behaviours related to ribonuclease A.Communicated by Ramaswamy H. Sarma
- 4 August 2023
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 42 (13) , 1-17
Mechanistic studies on substrate inhibition and substrate activation of ribonuclease A: experimental and in silico investigation
Ribonuclease A (RNase A) is an endonuclease that plays a significant role in antimicrobial activity by the cleavage and hydrolysis of ssRNA. In this study, the interactions between RNase A and cCMP have been investigated, through molecular docking and a 200 ns molecular dynamics simulation. The enzyme kinetic properties were analyzed using saturation curve, Eadie-Hofstee, and Hill plots. The docking results indicate that the cCMP-RNase A complexes are stabilized through hydrophobic interaction, hydrogen bonding, and & pi;-& pi; stacking interaction. The most binding site is observed in the catalytic cleft, especially at residue His12 and His119. Enzyme-ligand docking study indicates that cCMP binds to residues located in the internal cavity of the catalytic site and shows three phases of binding modes. The analysis of MD simulations shows that RMSD, Rg, and RMSF reach equilibrium. The & UDelta;G(binding) of the cCMP-RNase A was negative (-619.673 kJ/mol), The comparison between the results pre and post MD simulation showed that & UDelta;G(binding) after MD simulation causes to more stable the structure than before simulation. Experimental methods such as saturation, Eadie-Hofstee, and Hill plots confirm theoretical data and show three phases of binding modes as well. Two significant events are demonstrated in the interaction between RNase A and cCMP: substrate activation and substrate inhibition are observed in concentrations below and above 0.8 mM, respectively, for cCMP. Choosing the appropriate concentration of cCMP is very important in investigation of ribonuclease A's catalytic behavour, especially for exploration of the effects of some drugs on biological behaviours related to ribonuclease A.Communicated by Ramaswamy H. Sarma
- Open Access
- 20 December 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-13
The novel anti-cancer feature of Brazzein through activating of hTLR5 by integration of biological evaluation: molecular docking and molecular dynamics simulation
Many of plant proteins exhibit the properties similar to the antitumor proteins although the anticancer activity of Brazzein on modulating the autophagy signaling pathway has not been determined so far. The present study aimed to develop a simplified system to enable the rational design of the activating extracellular domain of human Toll-like receptor 5 (hTLR5). To identify the anticancer effect of Brazzein, HADDOCK program and molecular dynamics (MD) simulation were applied to examine the binding of the wild type (WT) and p.A19K mutant of Brazzein to the TLR5. The expression of MAP1S and TNF-α genes was estimated based on real-time PCR. The results clearly confirmed that the WT of Brazzein activated hTLR5 in the MCF-7 cell line since the genes were more and significantly less expressed in the cells treated with the WT and p.A19K mutant than the control, respectively. The snapshots of MD simulation exhibit the consistent close interactions of hTLR5 with the two helices of Brazzein on its lateral side. The results of per residue-free energy decomposition analysis substantiate those of intermolecular contact analysis perfectly one. We propose that the WT of Brazzein can act as an antitumor drug candidate.
- 20 December 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-13
Open AccessThe novel anti-cancer feature of Brazzein through activating of hTLR5 by integration of biological evaluation: molecular docking and molecular dynamics simulation
Many of plant proteins exhibit the properties similar to the antitumor proteins although the anticancer activity of Brazzein on modulating the autophagy signaling pathway has not been determined so far. The present study aimed to develop a simplified system to enable the rational design of the activating extracellular domain of human Toll-like receptor 5 (hTLR5). To identify the anticancer effect of Brazzein, HADDOCK program and molecular dynamics (MD) simulation were applied to examine the binding of the wild type (WT) and p.A19K mutant of Brazzein to the TLR5. The expression of MAP1S and TNF-α genes was estimated based on real-time PCR. The results clearly confirmed that the WT of Brazzein activated hTLR5 in the MCF-7 cell line since the genes were more and significantly less expressed in the cells treated with the WT and p.A19K mutant than the control, respectively. The snapshots of MD simulation exhibit the consistent close interactions of hTLR5 with the two helices of Brazzein on its lateral side. The results of per residue-free energy decomposition analysis substantiate those of intermolecular contact analysis perfectly one. We propose that the WT of Brazzein can act as an antitumor drug candidate.
- Open Access
- 1 March 2022
- Vol. 24 (3) , 105-111
Protective Effect of Low Dose of Methamphetamine on The Amount of Extracellular Glutamine in Primary Fetal Human Astrocytes Induced by Amyloid Beta
Objective: Change in astrocytes is one of the first pathological symptoms of Alzheimer's disease (AD). Understanding the signaling pathways in astrocytes can be a great help in treating of AD. This study aimed to investigate signaling pathway relations between low dose of methamphetamine (METH), the apoptosis, cell cycle, and glutamine (Gln) pathways in the activated astrocyte. Materials and Methods: In this experimental study, the activated astrocyte cells were exposed to a low dose of METH (12.5 mu M) which was determined by Thiazolyl blue tetrazolium bromide (MTT) method. The groups were: group 1 cells with A beta, group 2 cells with METH, group 3 cells with METH after 24 hours of adding A beta (A beta+METH, treated group), group 4 cells with A beta after 24 hours of adding METH (METH+A beta, prevention group), and group 5 as the control. The Gln was assayed by high-performance liquid chromatography (HPLC), and also the apoptosis, and cell cycle and BAX, BCL-X expression was evaluated. Results: The amount of Gln was increased, and the value of late and early apoptosis was reduced in the treatment groups, and necrosis is decreased in the prevention group (group 4 compared to group 1). Moreover, it was revealed through cell cycle analysis that G2 in group 4 was reduced compared to group 1 and the expression of BAX, BAX/ BCL-X, and BCL-X in group 3 and group 4, was decreased and increased, respectively compared to group 1. Conclusion: These findings suggest that perhaps a non-toxic dosage of METH (low dose) can reduce the amount of apoptosis and BAX expression and increase the expression of BCL-X. Furthermore, the cells are arrested in the G2 phase and can raise the amount of extracellular glutamine, which has a protective role in neuron cells. These findings may provide a new perspective to design a new drug with less toxic results.
- 1 March 2022
- Vol. 24 (3) , 105-111
Open AccessProtective Effect of Low Dose of Methamphetamine on The Amount of Extracellular Glutamine in Primary Fetal Human Astrocytes Induced by Amyloid Beta
Objective: Change in astrocytes is one of the first pathological symptoms of Alzheimer's disease (AD). Understanding the signaling pathways in astrocytes can be a great help in treating of AD. This study aimed to investigate signaling pathway relations between low dose of methamphetamine (METH), the apoptosis, cell cycle, and glutamine (Gln) pathways in the activated astrocyte. Materials and Methods: In this experimental study, the activated astrocyte cells were exposed to a low dose of METH (12.5 mu M) which was determined by Thiazolyl blue tetrazolium bromide (MTT) method. The groups were: group 1 cells with A beta, group 2 cells with METH, group 3 cells with METH after 24 hours of adding A beta (A beta+METH, treated group), group 4 cells with A beta after 24 hours of adding METH (METH+A beta, prevention group), and group 5 as the control. The Gln was assayed by high-performance liquid chromatography (HPLC), and also the apoptosis, and cell cycle and BAX, BCL-X expression was evaluated. Results: The amount of Gln was increased, and the value of late and early apoptosis was reduced in the treatment groups, and necrosis is decreased in the prevention group (group 4 compared to group 1). Moreover, it was revealed through cell cycle analysis that G2 in group 4 was reduced compared to group 1 and the expression of BAX, BAX/ BCL-X, and BCL-X in group 3 and group 4, was decreased and increased, respectively compared to group 1. Conclusion: These findings suggest that perhaps a non-toxic dosage of METH (low dose) can reduce the amount of apoptosis and BAX expression and increase the expression of BCL-X. Furthermore, the cells are arrested in the G2 phase and can raise the amount of extracellular glutamine, which has a protective role in neuron cells. These findings may provide a new perspective to design a new drug with less toxic results.
- 23 November 2021
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (3) , 1799-1816
PIK3CA hotspot mutations p. H1047R and p. H1047L sensitize breast cancer cells to thymoquinone treatment by regulating the PI3K/Akt1 pathway
Background Nigella sativa (N. sativa) exhibits anti-inflammatory, antioxidant, antidiabetic, antimetastatic and antinociceptive effects and has been used to treat dozens of diseases. Thymoquinone (TQ) is an important and active component isolated from N. sativa seeds. Inhibition of cancer-associated activating PIK3CA mutations is a new prospective targeted therapy in personalized metastatic breast cancer (MBC). TQ is reported to be an effective inhibitor of the PI3K/Akt1 pathway in MBC. This study aimed to evaluate the in vitro antitumor effect of TQ in the context of two PIK3CA hotspot mutations, p. H1047R and p. H1047L. Methods and results Molecular dynamics, free energy landscapes and principal component analyses were also used to survey the mechanistic effects of the p. H1047R and p. H1047L mutations on the PI3K/Akt1 pathway. Our findings clearly confirmed that the p. H1047R and p. H1047L mutants could reduce the inhibitory effect of ΔNp63α on the kinase domain of PIK3CA, resulting in increased activity of PI3K downstream signals. Structurally, the partial disruption of the interaction between the ΔNp63α DNA binding domain and the PIK3CA kinase domain at residues 114–359 and 797–1068 destabilizes the conformation of the activation loop and modifies the PIK3CA/ΔNp63α complex. Alongside these structural changes, we found that TQ treatment resulted in high PI3K/Akt1 pathway inhibition in p. H1047R and p. H1047L-expressing cells versus wild-type cells. Conclusions These two PIK3CA hotspot mutations therefore not only contribute to tumor progression in patients with MBC but may also serve as targets for the development of novel small molecule therapeutic strategies.
- 23 November 2021
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (3) , 1799-1816
PIK3CA hotspot mutations p. H1047R and p. H1047L sensitize breast cancer cells to thymoquinone treatment by regulating the PI3K/Akt1 pathway
Background Nigella sativa (N. sativa) exhibits anti-inflammatory, antioxidant, antidiabetic, antimetastatic and antinociceptive effects and has been used to treat dozens of diseases. Thymoquinone (TQ) is an important and active component isolated from N. sativa seeds. Inhibition of cancer-associated activating PIK3CA mutations is a new prospective targeted therapy in personalized metastatic breast cancer (MBC). TQ is reported to be an effective inhibitor of the PI3K/Akt1 pathway in MBC. This study aimed to evaluate the in vitro antitumor effect of TQ in the context of two PIK3CA hotspot mutations, p. H1047R and p. H1047L. Methods and results Molecular dynamics, free energy landscapes and principal component analyses were also used to survey the mechanistic effects of the p. H1047R and p. H1047L mutations on the PI3K/Akt1 pathway. Our findings clearly confirmed that the p. H1047R and p. H1047L mutants could reduce the inhibitory effect of ΔNp63α on the kinase domain of PIK3CA, resulting in increased activity of PI3K downstream signals. Structurally, the partial disruption of the interaction between the ΔNp63α DNA binding domain and the PIK3CA kinase domain at residues 114–359 and 797–1068 destabilizes the conformation of the activation loop and modifies the PIK3CA/ΔNp63α complex. Alongside these structural changes, we found that TQ treatment resulted in high PI3K/Akt1 pathway inhibition in p. H1047R and p. H1047L-expressing cells versus wild-type cells. Conclusions These two PIK3CA hotspot mutations therefore not only contribute to tumor progression in patients with MBC but may also serve as targets for the development of novel small molecule therapeutic strategies.
- 10 August 2021
- Published by Springer Nature in Molecular Biology Reports
- Vol. 48 (8) , 6103-6112
Alteration of gene expression in reactive astrocytes induced by Aβ1-42 using low dose of methamphetamine
Background Alzheimer's disease (AD) is a degenerative brain disorder. Due to the relationship between the functional loss of astrocytes and AD, the present study aims to evaluate the effects of the low dose of methamphetamine (METH) on primary fetal human astrocytes under a stress paradigm as a possible model for AD. Methods and results The groups in this study included Aβ (Group 1), METH (Group 2), Aβ + METH (METH after adding Aβ for 24 h) (Group 3 as treated group), METH + Aβ (Aβ after adding METH for 24 h) (Group 4 as prevention group), and control group. Then, the gene expression of Bax, Bcl-X, PKCα, GSK3β, and Cdk5 was evaluated. In addition, phosphorylated tau, p-GSK3β, GSK3β, and GSK3α proteins were assessed by western blotting. Further, cell cycle arrest and apoptosis were checked by flow cytometry and Hoechst staining. Based on the results, the expression of GSK3β, Cdk5, and PKCα genes decreased in the prevention group, while GSK3β and Cdk5 were amplified in the treatment group. Furthermore, the level of GSK3α and GSK3β proteins in the treatment group increased, while it decreased in the prevention group. Additionally, a decrease occurred in the percentage of necrosis and early apoptosis in the treatment and prevention groups. The results of the cell cycle indicated that G1 increased, while G2 decreased in the prevention group. Conclusion The pure form of METH can prevent from activating GSK-3β and CdK-5, as well as enhanced activity of PKCα to inhibit phosphorylated tau protein. Therefore, a low dose of METH may have a protective effect or reducing role in the pathway of tau production in reactive astrocytes.
- 10 August 2021
- Published by Springer Nature in Molecular Biology Reports
- Vol. 48 (8) , 6103-6112
Alteration of gene expression in reactive astrocytes induced by Aβ1-42 using low dose of methamphetamine
Background Alzheimer's disease (AD) is a degenerative brain disorder. Due to the relationship between the functional loss of astrocytes and AD, the present study aims to evaluate the effects of the low dose of methamphetamine (METH) on primary fetal human astrocytes under a stress paradigm as a possible model for AD. Methods and results The groups in this study included Aβ (Group 1), METH (Group 2), Aβ + METH (METH after adding Aβ for 24 h) (Group 3 as treated group), METH + Aβ (Aβ after adding METH for 24 h) (Group 4 as prevention group), and control group. Then, the gene expression of Bax, Bcl-X, PKCα, GSK3β, and Cdk5 was evaluated. In addition, phosphorylated tau, p-GSK3β, GSK3β, and GSK3α proteins were assessed by western blotting. Further, cell cycle arrest and apoptosis were checked by flow cytometry and Hoechst staining. Based on the results, the expression of GSK3β, Cdk5, and PKCα genes decreased in the prevention group, while GSK3β and Cdk5 were amplified in the treatment group. Furthermore, the level of GSK3α and GSK3β proteins in the treatment group increased, while it decreased in the prevention group. Additionally, a decrease occurred in the percentage of necrosis and early apoptosis in the treatment and prevention groups. The results of the cell cycle indicated that G1 increased, while G2 decreased in the prevention group. Conclusion The pure form of METH can prevent from activating GSK-3β and CdK-5, as well as enhanced activity of PKCα to inhibit phosphorylated tau protein. Therefore, a low dose of METH may have a protective effect or reducing role in the pathway of tau production in reactive astrocytes.
- 11 June 2021
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 88 (05) , 367-379
Protection of Beta Boswellic Acid against Streptozotocin-induced Alzheimerʼs Model by Reduction of Tau Phosphorylation Level and Enhancement of Reelin Expression
Alzheimerʼs disease is a growing general health concern with huge implications for individuals and society. Beta boswellic acid, a major compound of the Boswellia serrata plant, has long been used for the treatment of various inflammatory diseases. The exact mechanism of beta boswellic acid action in Alzheimerʼs disease pathogenesis remains unclear. In the current study, the protective effect of beta boswellic acid on streptozotocin-induced sporadic Alzheimerʼs disease was surveyed. Alzheimerʼs disease model was induced using streptozotocin followed by an assessment of the treatment effects of beta boswellic acid in the presence of streptozotocin. The prevention effect of beta boswellic acid on Alzheimerʼs disease induction by streptozotocin was evaluated. Behavioral activities in the treated rats were evaluated. Histological analysis was performed. Phosphorylation of tau protein at residues Ser396 and Ser404 and the expression of reelin protein were determined. Glial fibrillary acidic protein immunofluorescence staining was applied in the hippocampus regions. Our findings indicated that beta boswellic acid decreased traveled distance and escape latency in the prevention (beta boswellic acid + streptozotocin) and treatment (streptozotocin + beta boswellic acid) groups compared to control during the acquisition test. It increased “time spent” (%) in the target quadrant. Reelin level was enhanced in rats treated with beta boswellic acid. Tau hyperphosphorylation (p-tau404) and glial fibrillary acidic protein were decreased in the prevention group while the expression of reelin protein in both groups was increased. We could suggest that the anti-inflammatory property of beta boswellic acid is one of the main factors involving in the improvement of learning and memory in rats. Therefore the antineurodegenerative effect of beta boswellic acid may be due to its ability to reactivate reelin protein.
- 11 June 2021
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 88 (05) , 367-379
Protection of Beta Boswellic Acid against Streptozotocin-induced Alzheimerʼs Model by Reduction of Tau Phosphorylation Level and Enhancement of Reelin Expression
Alzheimerʼs disease is a growing general health concern with huge implications for individuals and society. Beta boswellic acid, a major compound of the Boswellia serrata plant, has long been used for the treatment of various inflammatory diseases. The exact mechanism of beta boswellic acid action in Alzheimerʼs disease pathogenesis remains unclear. In the current study, the protective effect of beta boswellic acid on streptozotocin-induced sporadic Alzheimerʼs disease was surveyed. Alzheimerʼs disease model was induced using streptozotocin followed by an assessment of the treatment effects of beta boswellic acid in the presence of streptozotocin. The prevention effect of beta boswellic acid on Alzheimerʼs disease induction by streptozotocin was evaluated. Behavioral activities in the treated rats were evaluated. Histological analysis was performed. Phosphorylation of tau protein at residues Ser396 and Ser404 and the expression of reelin protein were determined. Glial fibrillary acidic protein immunofluorescence staining was applied in the hippocampus regions. Our findings indicated that beta boswellic acid decreased traveled distance and escape latency in the prevention (beta boswellic acid + streptozotocin) and treatment (streptozotocin + beta boswellic acid) groups compared to control during the acquisition test. It increased “time spent” (%) in the target quadrant. Reelin level was enhanced in rats treated with beta boswellic acid. Tau hyperphosphorylation (p-tau404) and glial fibrillary acidic protein were decreased in the prevention group while the expression of reelin protein in both groups was increased. We could suggest that the anti-inflammatory property of beta boswellic acid is one of the main factors involving in the improvement of learning and memory in rats. Therefore the antineurodegenerative effect of beta boswellic acid may be due to its ability to reactivate reelin protein.
- Open Access
- 17 May 2021
- Published by Springer Nature in Research Square
Alteration of Gene Expression in Reactive Astrocytes Induced by Aβ1-42 Using Low Dose of Methamphetamine
Background: Alzheimer's disease (AD) is considered as a degenerative brain disorder. Since functional loss of astrocytes is associated with AD, therefore, we investigated the effects of low dose of methamphetamine (METH) on primary fetal human astrocytes under a stress paradigm as a possible model for AD. Methods and Results: Our assessed groups include Aβ (Group 1), METH (Group 2), Ab + METH (METH after adding Aβ for 24 h: Treated group; Group 3), METH + Ab (Aβ after adding METH for 24 h: Prevention group; Group 4), and control group. The gene expression of Bax, Bcl-X, PKCα, GSK3β, and Cdk5 was evaluated. Phosphorylated tau, p-GSK3β, GSK3β, and GSK3α proteins were assessed by western blotting. Cell cycle arrest and apoptosis were checked by flow cytometry and Hoechst staining. The expression of GSK3β, Cdk5, and PKCα genes decreased in the prevention group, while GSK3β and Cdk5 were amplified in the treatment group. The level of GSK3α and GSK3β proteins in the treatment group increased, while it decreased in the prevention group. A decrease occurred in the percentage of necrosis and early apoptosis in the treatment and prevention groups. The results of cell cycle indicated that G1 increased, while G2 decreased in the prevention group. Conclusions: The pure form of METH can prevent from activating GSK-3β and CDK-5, as well as enhanced activity of PKCa to inhibit phosphorylated tau protein. Therefore a low dose of METH may have a protective effect or reducing role in the pathway of tau production in reactive astrocytes.
- 17 May 2021
- Published by Springer Nature in Research Square
Open AccessAlteration of Gene Expression in Reactive Astrocytes Induced by Aβ1-42 Using Low Dose of Methamphetamine
Background: Alzheimer's disease (AD) is considered as a degenerative brain disorder. Since functional loss of astrocytes is associated with AD, therefore, we investigated the effects of low dose of methamphetamine (METH) on primary fetal human astrocytes under a stress paradigm as a possible model for AD. Methods and Results: Our assessed groups include Aβ (Group 1), METH (Group 2), Ab + METH (METH after adding Aβ for 24 h: Treated group; Group 3), METH + Ab (Aβ after adding METH for 24 h: Prevention group; Group 4), and control group. The gene expression of Bax, Bcl-X, PKCα, GSK3β, and Cdk5 was evaluated. Phosphorylated tau, p-GSK3β, GSK3β, and GSK3α proteins were assessed by western blotting. Cell cycle arrest and apoptosis were checked by flow cytometry and Hoechst staining. The expression of GSK3β, Cdk5, and PKCα genes decreased in the prevention group, while GSK3β and Cdk5 were amplified in the treatment group. The level of GSK3α and GSK3β proteins in the treatment group increased, while it decreased in the prevention group. A decrease occurred in the percentage of necrosis and early apoptosis in the treatment and prevention groups. The results of cell cycle indicated that G1 increased, while G2 decreased in the prevention group. Conclusions: The pure form of METH can prevent from activating GSK-3β and CDK-5, as well as enhanced activity of PKCa to inhibit phosphorylated tau protein. Therefore a low dose of METH may have a protective effect or reducing role in the pathway of tau production in reactive astrocytes.
- Open Access
- 1 November 2019
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 10 (6) , 545-556
Protein Kinase Cε in the Platelet and Hippocampal Tissue as a Diagnostic Biological Marker in Alzheimer Disease
Introduction: Alzheimer disease (AD) is a neurodegenerative disorder characterized by the progressive loss of memory and other cognitive functions. Protein kinase Cε (PKCε) is an isoform that most effectively suppresses amyloid beta (Aβ) production and synaptic loss. Methods: In this study, spatial learning and memory for treated rats were evaluated by ...
- 1 November 2019
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 10 (6) , 545-556
Open AccessProtein Kinase Cε in the Platelet and Hippocampal Tissue as a Diagnostic Biological Marker in Alzheimer Disease
Introduction: Alzheimer disease (AD) is a neurodegenerative disorder characterized by the progressive loss of memory and other cognitive functions. Protein kinase Cε (PKCε) is an isoform that most effectively suppresses amyloid beta (Aβ) production and synaptic loss. Methods: In this study, spatial learning and memory for treated rats were evaluated by ...
- Open Access
- 1 December 2018
- Vol. 17 (1) , 63-74
The importance of α-CT and Salt bridges in the Formation of Insulin and its Receptor Complex by Computational Simulation
Insulin hormone is an important part of the endocrine system. It contains two polypeptide chains and plays a pivotal role in regulating carbohydrate metabolism. Insulin receptors (IR) located on cell surface interacts with insulin to control the intake of glucose. Although several studies have tried to clarify the interaction between insulin and its receptor, the mechanism of this interaction remains elusive because of the receptor's structural complexity and structural changes during the interaction. In this work, we tried to fractionate the interactions. Therefore, sequential docking method utilization of HADDOCK was used to achieve the mentioned goal, so the following processes were done: the first, two pdb files of IR i.e., 3LOH and 3W11 were concatenated using modeller. The second, flexible regions of IR were predicted by HingeProt. Output files resulting from HingeProt were uploaded into HADDOCK. Our results predict new salt bridges in the complex and emphasize on the role of salt bridges to maintain an inverted V structure of IR. Having an inverted V structure leads to activate intracellular signaling pathway. In addition to presence salt bridges to form a convenient structure of IR, the importance of alpha-chain of carboxyl terminal (alpha-CT) to interact with insulin was surveyed and also foretokened new insulin/IR contacts, particularly at site 2 (rigid parts 2 and 3). Finally, several conformational changes in residues Asn711-Val715 of alpha-CT were occurred, we suggest that alpha-CT is a suitable situation relative to insulin due to these conformational alterations.
- 1 December 2018
- Vol. 17 (1) , 63-74
Open AccessThe importance of α-CT and Salt bridges in the Formation of Insulin and its Receptor Complex by Computational Simulation
Insulin hormone is an important part of the endocrine system. It contains two polypeptide chains and plays a pivotal role in regulating carbohydrate metabolism. Insulin receptors (IR) located on cell surface interacts with insulin to control the intake of glucose. Although several studies have tried to clarify the interaction between insulin and its receptor, the mechanism of this interaction remains elusive because of the receptor's structural complexity and structural changes during the interaction. In this work, we tried to fractionate the interactions. Therefore, sequential docking method utilization of HADDOCK was used to achieve the mentioned goal, so the following processes were done: the first, two pdb files of IR i.e., 3LOH and 3W11 were concatenated using modeller. The second, flexible regions of IR were predicted by HingeProt. Output files resulting from HingeProt were uploaded into HADDOCK. Our results predict new salt bridges in the complex and emphasize on the role of salt bridges to maintain an inverted V structure of IR. Having an inverted V structure leads to activate intracellular signaling pathway. In addition to presence salt bridges to form a convenient structure of IR, the importance of alpha-chain of carboxyl terminal (alpha-CT) to interact with insulin was surveyed and also foretokened new insulin/IR contacts, particularly at site 2 (rigid parts 2 and 3). Finally, several conformational changes in residues Asn711-Val715 of alpha-CT were occurred, we suggest that alpha-CT is a suitable situation relative to insulin due to these conformational alterations.